3.10
5.44%
0.16
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNGX Giù?
Forum
Previsione
Tango Therapeutics Inc Azioni (TNGX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
19.15%
6.471
|
5.431 | 10.73 | 14.60 | 5.766 |
Operating Expenses
|
20.48%
48.73
|
40.44 | 36.36 | 37.84 | 36.05 |
Benefits Costs and Expenses |
22.68%
44.34
|
36.15 | 32.97 | 35.24 | - |
Costs And Expenses |
22.68%
44.34
|
36.15 | 32.97 | 35.24 | 36.05 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
20.68%
-42.26
|
-35.01 | -25.63 | -23.25 | -30.29 |
Net Interest Income/Expense |
1.74%
2.197
|
2.236 | 1.872 | 1.45 | 1.061 |
Nonoperating Income/Loss |
1.95%
4.381
|
4.297 | 3.386 | 2.601 | 2.278 |
Income/Loss From Continuing Operations Before Tax |
23.30%
-37.87
|
-30.72 | -22.24 | -20.65 | -28.01 |
Income Tax Expense/Benefit |
14.89%
0.04
|
0.047 | 0.023 | 0.064 | - |
Income/Loss From Continuing Operations After Tax |
23.25%
-37.91
|
-30.76 | -22.26 | -20.71 | -28.01 |
Net Income/Loss
|
23.25%
-37.91
|
-30.76 | -22.26 | -20.71 | -28.01 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
3,174%
108.17
|
3.3043 | 97.03 | 88.35 | 88.19 |
Diluted Average Shares |
3,174%
108.17
|
3.3043 | 97.03 | 88.35 | 88.19 |
Basic Earnings Per Share |
16.67%
-0.35
|
-0.30 | -0.23 | -0.23 | -0.32 |
Diluted Earnings Per Share |
16.67%
-0.35
|
-0.30 | -0.23 | -0.23 | -0.32 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):